Program & Speakers

Efficacy and Safety of a Novel Bi-phasic Drospirenone-Only Pill for Endometriosis-Associated Pelvic Pain: Results from a Phase III Randomised Trial

Tracks

Track 1

Monday, August 10, 2026

11:15 AM - 11:30 AM

Murray & Fitzroy Rooms

Overview

Anita Townsend

Speaker

Agenda Item Image

Pedro-Antonio Regidor

Medical Director Exeltis Europe & Global Projects

Exeltis Pharmaceuticals

Efficacy and Safety of a Novel Bi-phasic Drospirenone-Only Pill for Endometriosis-Associated Pelvic Pain: Results from a Phase III Randomised Trial

You need to enable JavaScript to access this site.

Follow these instructions on how to enable JavaScript.

Internet Explorer

Select Tools from the top menu
Choose Internet Options
Click on the Security tab
Click on Custom Level
Scroll down until you see the section labelled Scripting
Under Active Scripting, select Enable and click OK

Google Chrome

Select the menu icon on the browser toolbar
Select Settings
Click the Show advanced settings... link then Content Settings in the Privacy section
Select Allow all sites to run JavaScript (recommended) and click Done

Safari (Mac)

Select Safari from the top menu
Choose Preferences
Choose Security
Select the checkbox next to Enable JavaScript